What Is Measles?

Measles is an acute infectious disease caused by measles morbillivirus, a single-stranded negative-sense RNA virus of the family Paramyxoviridae with no animal reservoir. It is among the most transmissible pathogens known to affect humans and produces a characteristic sequence of fever, cough, coryza, conjunctivitis, and a maculopapular rash. Humans are its only natural host, a fact that makes global eradication biologically feasible and that has kept the disease at the center of immunization policy since a live attenuated vaccine became available in 1963.

The virus enters through the respiratory tract, replicates in alveolar macrophages and dendritic cells, and spreads through the lymphatic system before a secondary viremia disseminates it to the skin, conjunctivae, and other epithelial surfaces. The World Health Organization fact sheet on measles records roughly 95,000 deaths in 2024, concentrated among unvaccinated children under five, alongside an estimated 88 percent reduction in mortality since 2000.

Transmission and Reproduction Number

Measles spreads by respiratory droplets and by airborne aerosol that stays infectious in a room for up to two hours after an infected person leaves it. The basic reproduction number, the average number of secondary cases produced by one case in a fully susceptible population, is conventionally quoted between 12 and 18, though analyses of the complexity of the basic reproduction number stress that the value depends on contact structure, population density, and modeling assumptions rather than being a fixed property of the virus. A reproduction number in that range implies a herd immunity threshold near 92 to 95 percent, which is why measles is usually the first vaccine-preventable disease to return when coverage falls.

Clinical Course and Complications

After an incubation period of about 10 to 14 days, a prodrome of high fever and respiratory symptoms precedes the rash by several days, with Koplik spots on the buccal mucosa serving as an early diagnostic sign. Complications include otitis media, diarrhea, and pneumonia, which accounts for most measles deaths, along with acute disseminated encephalomyelitis and the rare, invariably fatal subacute sclerosing panencephalitis that can appear years later. Infection also depletes existing memory B and T cell populations, an immune amnesia that raises susceptibility to unrelated pathogens for months. Laboratory confirmation relies on IgM serology and reverse transcription PCR, with genotyping used to trace transmission chains.

Vaccination and Elimination Programs

Two doses of a measles-containing vaccine confer protection in roughly 97 percent of recipients, and the vaccine is usually delivered in combination with mumps and rubella components. Surveillance distinguishes primary vaccine failure, in which no immune response develops, from secondary failure, in which immunity wanes; work on onward transmission after secondary vaccination failure indicates that such cases are substantially less infectious than cases in unvaccinated people. Elimination, defined as the absence of endemic transmission for at least 12 months, has been achieved and then lost in several regions as coverage declined, and outbreak response depends on rapid case detection, contact tracing, and supplementary immunization activities.

Applications

Measles research connects to a range of technical disciplines, including:

• Epidemiological modeling, where the disease serves as a benchmark for compartmental and network transmission models
• Vaccine cold chain engineering, including thermostable formulations and microneedle patch delivery
• Diagnostic device development, covering point-of-care serology and portable nucleic acid amplification
• Digital public health, in immunization registries, coverage estimation, and outbreak surveillance systems
• Building ventilation and infection control design, given the airborne transmission route
• Oncolytic virotherapy, which uses engineered measles virus strains as tumor-targeting agents